Putting The I in Pills
Individualised medicine has so far failed to live up to the hype but innovations in the field are on the cusp of disrupting the way pharma and healthcare develop and provide treatments.
Close log in window
Compassionate use programs offer hope to patients who have ran out of options. But the benefits must be weighed against the risks.
If real-world data is to deliver on its promise, it needs to be standardized
The potential of blockchain to better manage RWE and access makes it an exciting prospect. However, pharma first needs to get its head aroun...
